Europe Lung Cancer Screening Software Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143148
- Pages: 225
-
Format:
Short Description
Europe Lung Cancer Screening Software Market, By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACS, Practice Management, and Audit Log Tracking), Mode of Delivery (Web Based Solutions, On-Premise Solutions, and Based Solutions), Type (Computer Assisted Screening and Traditional Screening), Application (Small Cell Lung Cancer and Non-Small Cell Lung Cancer), Platform (Standalone and Integrated), Purchase Mode (Individual and Institutional), End User (Hospitals, Oncology Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender and Third Party Distributors), Countries (Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Belgium, Turkey, and Rest of Europe) Industry Trends and Forecast to 2029
Market Definition
Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique of screening lung cancer. Rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. These software help to manage patients participation in lung screening programs and provide an efficient way for healthcare professionals to collect, curate, and transfer data to clinicians and patients. In addition, these software enable in identifying patients at risk and automates flow of data with integrated electronic health records.
Market Segmentation
Europe lung cancer screening software market is divided into seven notable segments which are based on product, mode of delivery, type, application, platform, purchase mode, end user, and distribution channel.
On the basis of product, the market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACS, practice management, and audit log tracking
On the basis of mode of delivery, the market is segmented into cloud based solutions, on-premise solutions, and web based solutions
On the basis of type, the market is segmented into computer-assisted screening and traditional screening
On the basis of application, the market is segmented into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
On the basis of platform, the market is segmented into standalone and integrated
On the basis of purchase mode, the market is segmented into individual and institutional
On the basis of end user, the market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others
On the basis of distribution channel, the market is segmented into direct tender and third party distributors
Market Players
Some of the major players operating in the Europe lung cancer screening software market are:
Koninklijke Philiphs N.V
Siemens Healthcare GmbH
Nuance Communication, Inc.
General Electric Company
Oncocyte Corporation
Aidence.com
AstraZeneca
Canon Medical Informatics, Inc.
Coreline Soft, Co., Ltd.
Eon
Epic Systems Corporation
F. Hoffmann-La Roche Ltd
FUJIFILM Holdings Corporation
Genesystem
HealthMyne
Lungview
MagView
Median Technologies
Medtronic
MeVis Medical Solutions AG
MyCareWare Inc.
Optellum Ltd
PenRad Technologies Inc.
REVEALDX
Thynk Health
Volpara Health Limited
TABLE OF CONTENTS
1 INTRODUCTION 61
1.1 OBJECTIVES OF THE STUDY 61
1.2 MARKET DEFINITION 61
1.3 OVERVIEW OF EUROPE LUNG CANCER SCREENING SOFTWARE MARKET 61
1.4 LIMITATION 63
1.5 MARKETS COVERED 64
2 MARKET SEGMENTATION 67
2.1 MARKETS COVERED 67
2.2 GEOGRAPHICAL SCOPE 68
2.3 YEARS CONSIDERED FOR THE STUDY 69
2.4 CURRENCY AND PRICING 69
2.5 DBMR TRIPOD DATA VALIDATION MODEL 70
2.6 MULTIVARIATE MODELLING 73
2.7 PRODUCT LIFELINE CURVE 73
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 74
2.9 DBMR MARKET POSITION GRID 75
2.10 VENDOR SHARE ANALYSIS 77
2.11 SECONDARY SOURCES 78
2.12 ASSUMPTIONS 78
3 EXECUTIVE SUMMARY 79
4 PREMIUM INSIGHTS 83
5 REGULATIONS & REIMBURSEMENT 84
6 MARKET OVERVIEW 85
6.1 DRIVERS 87
6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES EUROPELY 87
6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING 87
6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 88
6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE 88
6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 89
6.2 RESTRAINTS 90
6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE 90
6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS 90
6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS 90
6.3 OPPORTUNITIES 91
6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS 91
6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS 92
6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE 92
6.4 CHALLENGES 93
6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES 93
6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE 93
6.4.3 INCREASING COMPETITION IN THE MARKET 94
7 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY 95
7.1 OVERVIEW 96
7.2 CLOUD BASED SOLUTIONS 97
7.3 ON-PREMISE SOLUTIONS 98
7.4 WEB BASED SOLUTIONS 98
8 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT 100
8.1 OVERVIEW 101
8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION 103
8.2.1 ON-PREMISE SOLUTIONS 103
8.2.2 WEB BASED SOLUTIONS 104
8.2.3 CLOUD BASED SOLUTIONS 104
8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE 104
8.3.1 CLOUD BASED SOLUTIONS 105
8.3.2 ON-PREMISE SOLUTIONS 105
8.3.3 WEB BASED SOLUTIONS 105
8.4 NODULE MANAGEMENT SOFTWARE 105
8.4.1 CLOUD BASED SOLUTIONS 106
8.4.2 ON-PREMISE SOLUTIONS 106
8.4.3 WEB BASED SOLUTIONS 106
8.5 DATA COLLECTION AND REPORTING 107
8.5.1 CLOUD BASED SOLUTIONS 108
8.5.2 WEB BASED SOLUTIONS 108
8.5.3 ON-PREMISE SOLUTIONS 108
8.6 PATIENT COORDINATION AND WORKFLOW 108
8.6.1 CLOUD BASED SOLUTIONS 109
8.6.2 ON-PREMISE SOLUTIONS 109
8.6.3 WEB BASED SOLUTIONS 109
8.7 LUNG NODULE COMPUTER AIDED DETECTION 109
8.7.1 ON-PREMISE SOLUTIONS 110
8.7.2 CLOUD BASED SOLUTIONS 110
8.7.3 WEB BASED SOLUTIONS 110
8.8 PATHOLOGY AND CANCER STAGING 111
8.8.1 CLOUD BASED SOLUTIONS 112
8.8.2 ON-PREMISE SOLUTIONS 112
8.8.3 WEB BASED SOLUTIONS 112
8.9 STATISTICAL AUDIT REPORTING 112
8.9.1 CLOUD BASED SOLUTIONS 113
8.9.2 ON-PREMISE SOLUTIONS 113
8.9.3 WEB BASED SOLUTIONS 113
8.10 SCREENING PACS 113
8.10.1 CLOUD BASED SOLUTIONS 114
8.10.2 ON-PREMISE SOLUTIONS 114
8.10.3 WEB BASED SOLUTIONS 114
8.11 PRACTICE MANAGEMENT 114
8.11.1 CLOUD BASED SOLUTIONS 115
8.11.2 ON-PREMISE SOLUTIONS 116
8.11.3 WEB BASED SOLUTIONS 116
8.12 AUDIT LOG TRACKING 116
8.12.1 CLOUD BASED SOLUTIONS 117
8.12.2 ON-PREMISE SOLUTIONS 117
8.12.3 WEB BASED SOLUTIONS 117
9 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE 118
9.1 OVERVIEW 119
9.2 COMPUTER-ASSISTED SCREENING 120
9.2.1 CLOUD BASED SOLUTIONS 121
9.2.2 ON-PREMISE SOLUTIONS 121
9.2.3 WEB BASED SOLUTIONS 121
9.3 TRADITIONAL SCREENING 121
9.3.1 CLOUD BASED SOLUTIONS 122
9.3.2 ON-PREMISE SOLUTIONS 122
9.3.3 WEB BASED SOLUTIONS 122
10 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION 123
10.1 OVERVIEW 124
10.2 NON-SMALL CELL LUNG CANCER (NSCLC) 125
10.2.1 CLOUD BASED SOLUTIONS 126
10.2.2 ON-PREMISE SOLUTIONS 126
10.2.3 WEB BASED SOLUTIONS 126
10.3 SMALL CELL LUNG CANCER (SCLC) 126
10.3.1 CLOUD BASED SOLUTIONS 127
10.3.2 ON-PREMISE SOLUTIONS 127
10.3.3 WEB BASED SOLUTIONS 127
11 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM 128
11.1 OVERVIEW 129
11.2 STANDALONE 130
11.2.1 CLOUD BASED SOLUTIONS 131
11.2.2 ON-PREMISE SOLUTIONS 131
11.2.3 WEB BASED SOLUTIONS 131
11.3 INTEGRATED 131
11.3.1 CLOUD BASED SOLUTIONS 132
11.3.2 ON-PREMISE SOLUTIONS 132
11.3.3 WEB BASED SOLUTIONS 132
12 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE 133
12.1 OVERVIEW 134
12.2 INSTITUTIONAL 135
12.3 INDIVIDUAL 136
13 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER 137
13.1 OVERVIEW 138
13.2 ONCOLOGY CENTERS 139
13.3 HOSPITALS 140
13.4 AMBULATORY SURGICAL CENTERS 140
13.5 OTHERS 141
14 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL 142
14.1 OVERVIEW 143
14.2 DIRECT TENDERS 144
14.3 THIRD PARTY DISTRIBUTOR 145
15 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION 146
15.1 EUROPE 147
15.1.1 GERMANY 159
15.1.2 FRANCE 166
15.1.3 U.K. 173
15.1.4 ITALY 180
15.1.5 SPAIN 187
15.1.6 NETHERLANDS 194
15.1.7 RUSSIA 201
15.1.8 SWITZERLAND 208
15.1.9 BELGIUM 215
15.1.10 TURKEY 222
15.1.11 REST OF EUROPE 229
16 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE 230
16.1 COMPANY SHARE ANALYSIS: EUROPE 230
17 SWOT ANALYSIS 231
18 COMPANY PROFILE 232
18.1 KONINKLIJKE PHILIPS N.V 232
18.1.1 COMPANY SNAPSHOT 232
18.1.2 REVENUE ANALYSIS 232
18.1.3 COMPANY SHARE ANALYSIS 233
18.1.4 PRODUCT PORTFOLIO 233
18.1.5 RECENT DEVELOPMENTS 233
18.2 SIEMENS HEALTHCARE GMBH 235
18.2.1 COMPANY SNAPSHOT 235
18.2.2 REVENUE ANALYSIS 235
18.2.3 COMPANY SHARE ANALYSIS 236
18.2.4 PRODUCT PORTFOLIO 236
18.2.5 RECENT DEVELOPMENTS 236
18.3 NUANCE COMMUNICATIONS, INC. 238
18.3.1 COMPANY SNAPSHOT 238
18.3.2 REVENUE ANALYSIS 238
18.3.3 COMPANY SHARE ANALYSIS 239
18.3.4 PRODUCT PORTFOLIO 239
18.3.5 RECENT DEVELOPMENTS 239
18.4 GENRAL ELECTRIC (GE HEALTHCARE) 241
18.4.1 COMPANY SNAPSHOT 241
18.4.2 COMPANY SHARE ANALYSIS 241
18.4.3 PRODUCT PORTFOLIO 242
18.4.4 RECENT DEVELOPMENTS 242
18.5 ONCOCYTE CORPORATION 243
18.5.1 COMPANY SNAPSHOT 243
18.5.2 REVENUE ANALYSIS 243
18.5.3 COMPANY SHARE ANALYSIS 244
18.5.4 PRODUCT PORTFOLIO 244
18.5.5 RECENT DEVELOPMENT 244
18.6 AIDENCE.COM 245
18.6.1 COMPANY SNAPSHOT 245
18.6.3 PRODUCT PORTFOLIO 245
18.6.4 RECENT DEVELOPMENT 245
18.7 ASTRAZENECA 246
18.7.1 COMPANY SNAPSHOT 246
18.7.2 REVENUE ANALYSIS 246
18.7.3 PRODUCT PORTFOLIO 247
18.7.4 RECENT DEVELOPMENT 247
18.8 CANON MEDICAL INFORMATICS, INC. 248
18.8.1 COMPANY SNAPSHOT 248
18.8.2 PRODUCT PORTFOLIO 248
18.8.3 RECENT DEVELOPMENTS 248
18.9 CORELINE SOFT, CO., LTD. 249
18.9.1 COMPANY SNAPSHOT 249
18.9.2 PRODUCT PORTFOLIO 249
18.9.3 RECENT DEVELOPMENTS 249
18.10 EON 251
18.10.1 COMPANY SNAPSHOT 251
18.10.2 PRODUCT PORTFOLIO 251
18.10.3 RECENT DEVELOPMENT 251
18.11 EPIC SYSTEMS CORPORATION 252
18.11.1 COMPANY SNAPSHOT 252
18.11.2 PRODUCT PORTFOLIO 252
18.11.3 RECENT DEVELOPMENT 252
18.12 F. HOFFMANN-LA ROCHE LTD 253
18.12.1 COMPANY SNAPSHOT 253
18.12.2 REVENUE ANALYSIS 253
18.12.3 PRODUCT PORTFOLIO 254
18.12.4 RECENT DEVELOPMENTS 254
18.13 FUJIFILM HOLDINGS CORPORATION 255
18.13.1 COMPANY SNAPSHOT 255
18.13.2 REVENUE ANALYSIS 255
18.13.3 PRODUCT PORTFOLIO 256
18.13.4 RECENT DEVELOPMENTS 256
18.14 GENESYSTEM 257
18.14.1 COMPANY SNAPSHOT 257
18.14.2 PRODUCT PORTFOLIO 257
18.14.3 RECENT DEVELOPMENT 257
18.15 HEALTHMYNE 258
18.15.1 COMPANY SNAPSHOT 258
18.15.2 PRODUCT PORTFOLIO 258
18.15.3 RECENT DEVELOPMENTS 259
18.16 LUNGVIEW 260
18.16.1 COMPANY SNAPSHOT 260
18.16.2 PRODUCT PORTFOLIO 260
18.16.3 RECENT DEVELOPMENT 260
18.17 MAGVIEW 261
18.17.1 COMPANY SNAPSHOT 261
18.17.2 PRODUCT PORTFOLIO 261
18.17.3 RECENT DEVELOPMENT 261
18.18 MEDIAN TECHNOLOGIES 262
18.18.1 COMPANY SNAPSHOT 262
18.18.2 REVENUE ANALYSIS 262
18.18.3 PRODUCT PORTFOLIO 263
18.18.4 RECENT DEVELOPMENT 263
18.19 MEDTRONIC 264
18.19.1 COMPANY SNAPSHOT 264
18.19.2 REVENUE ANALYSIS 264
18.19.3 PRODUCT PORTFOLIO 265
18.19.4 RECENT DEVELOPMENTS 265
18.20 MEVIS MEDICAL SOLUTIONS AG 266
18.20.1 COMPANY SNAPSHOT 266
18.20.2 REVENUE ANALYSIS 266
18.20.3 PRODUCT PORTFOLIO 267
18.20.4 RECENT DEVELOPMENT 267
18.21 MYCAREWARE INC. 268
18.21.1 COMPANY SNAPSHOT 268
18.21.2 PRODUCT PORTFOLIO 268
18.21.3 RECENT DEVELOPMENT 268
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
